Michael Atkin

Amministratore Delegato presso

Ulysses Pharmaceuticals Products, Inc.

70 anni

Health Technology

Consumer Services

Profilo

Michael C.
Atkin is the founder of Syzent Partners Ltd. founded in 2008, where he holds the title of President.
He currently holds the positions of Executive Chairman, President & CEO at Ulysses Pharmaceuticals Products, Inc. and Director at Affinite Instruments.
Mr. Atkin's former positions include President & Chief Executive Officer at Aegera Therapeutics, Inc., President, Chief Executive Officer & Secretary at Gladius Pharmaceuticals Corp., Chairman at ChitogenX, Inc., Chairman at Sopharmia, Inc., Director at Genizon Biosciences, Inc., Director at Topigen Pharmaceuticals, Inc., and Principal at Bristol Myers Squibb Co. He also held the position of Vice President-Business Development at Lederle International.
Mr. Atkin received his undergraduate degree from the University of Kent and his MBA from Columbia Business School.

Posizioni attive di Michael Atkin

Società	Posizione	Inizio
Ulysses Pharmaceuticals Products, Inc. Ulysses Pharmaceuticals Products, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops antibiotics for empiric monotherapy to control resistant bacterial infections	Amministratore Delegato	-
Syzent Partners Ltd.	Fondatore	01/01/2008
Affinite Instruments Affinite Instruments Medical SpecialtiesHealth Technology Develops and manufactures SPR instruments	Direttore/Membro del Consiglio	-

Tutte le posizioni attive di Michael Atkin

Precedenti posizioni note di Michael Atkin

Società	Posizione	Fine
CHITOGENX INC.	Presidente	01/07/2022
Gladius Pharmaceuticals Corp. Gladius Pharmaceuticals Corp. BiotechnologyHealth Technology Operates as biotechnology firm	Amministratore Delegato	01/01/2019
Genizon Biosciences, Inc. Genizon Biosciences, Inc. BiotechnologyHealth Technology Provides drug development services	Direttore/Membro del Consiglio	30/05/2012
Sopharmia, Inc.	Presidente	-
Lederle International	Corporate Officer/Principal	-

Vedi nel dettaglio l'esperienza di Michael Atkin

Formazione di Michael Atkin

Esperienze
Posizioni ricoperte

Attive

Inattive

Società nel listino

Aziende private

Vedi nel dettaglio l'esperienza di Michael Atkin

Relazioni

Relazioni di 1° grado

Aziende connesse in 1º grado

Uomo

Donna

Amministratori

Dirigenti

Vedi i contatti personali

Società collegate

Aziende private	13
Bristol Myers Squibb Co. Bristol Myers Squibb Co. Pharmaceuticals: MajorHealth Technology Manufactures and markets biopharmaceuticals products	Health Technology
Genizon Biosciences, Inc. Genizon Biosciences, Inc. BiotechnologyHealth Technology Provides drug development services	Health Technology
Aegera Therapeutics, Inc. Aegera Therapeutics, Inc. BiotechnologyHealth Technology Manufactures and develops drugs	Health Technology
Topigen Pharmaceuticals, Inc. Topigen Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for respiratory diseases	Health Technology
Lederle International
Ulysses Pharmaceuticals Products, Inc. Ulysses Pharmaceuticals Products, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops antibiotics for empiric monotherapy to control resistant bacterial infections	Health Technology
University of Kent University of Kent Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Columbia Business School Columbia Business School Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Gladius Pharmaceuticals Corp. Gladius Pharmaceuticals Corp. BiotechnologyHealth Technology Operates as biotechnology firm	Health Technology
ChitogenX, Inc. ChitogenX, Inc. BiotechnologyHealth Technology Operates as a development stage biotechnology company	Health Technology
Syzent Partners Ltd.
Sopharmia, Inc.
Affinite Instruments Affinite Instruments Medical SpecialtiesHealth Technology Develops and manufactures SPR instruments	Health Technology